» Articles » PMID: 35286712

Cholinergic and Dopaminergic-mediated Motivated Behavior in Healthy States and in Substance Use and Mood Disorders

Overview
Date 2022 Mar 14
PMID 35286712
Authors
Affiliations
Soon will be listed here.
Abstract

Acetylcholine is an important neuromodulator of the mesolimbic dopamine (DA) system, which itself is a mediator of motivated behavior. Motivated behavior can be described by two primary components, termed directional and activational motivation, both of which can be examined and dissociated using effort-choice tasks. The directional component refers to motivated behavior directed towards reinforcing stimuli and away from aversive stimuli. Behaviors characterized by increased vigor, persistence, and work output are considered to reflect activational components of motivation. Disruption of DA signaling has been shown to decrease activational components of motivation, while leaving directional features intact. Facilitation of DA release promotes the activational aspects of motivated behavior. In this review, we discuss cholinergic and DA regulation of motivated behaviors. We place emphasis on effort-choice processes and the ability of effort-choice tasks to examine and dissociate changes of motivated behavior in the context of substance use and mood disorders. Furthermore, we consider how altered cholinergic transmission impacts motivated behavior across disease states, and the possible role of cholinergic dysregulation in the etiology of these illnesses. Finally, we suggest that treatments targeting cholinergic activity may be useful in ameliorating motivational disruptions associated with substance use and comorbid substance use and mood disorders.

Citing Articles

Targeting the Actions of Muscarinic Receptors on Dopamine Systems: New Strategies for Treating Neuropsychiatric Disorders.

Nunes E, Addy N, Conn P, Foster D Annu Rev Pharmacol Toxicol. 2023; 64():277-289.

PMID: 37552895 PMC: 10841102. DOI: 10.1146/annurev-pharmtox-051921-023858.


Ventral Tegmental Area M5 Muscarinic Receptors Mediate Effort-Choice Responding and Nucleus Accumbens Dopamine in a Sex-Specific Manner .

Nunes E, Kebede N, Haight J, Foster D, Lindsley C, Conn P J Pharmacol Exp Ther. 2023; 385(2):146-156.

PMID: 36828630 PMC: 10108441. DOI: 10.1124/jpet.122.001438.


L-type calcium channel regulation of dopamine activity in the ventral tegmental area to nucleus accumbens pathway: Implications for substance use, mood disorders and co-morbidities.

Nunes E, Addy N Neuropharmacology. 2022; 224:109336.

PMID: 36414149 PMC: 11215796. DOI: 10.1016/j.neuropharm.2022.109336.


Effects of propofol combined with lidocaine on hemodynamics, serum adrenocorticotropic hormone, interleukin-6, and cortisol in children.

Shi S, Gan L, Jin C, Liu R World J Clin Cases. 2022; 10(24):8506-8513.

PMID: 36157832 PMC: 9453372. DOI: 10.12998/wjcc.v10.i24.8506.

References
1.
Solecki W, Wickham R, Behrens S, Wang J, Zwerling B, Mason G . Differential role of ventral tegmental area acetylcholine and N-methyl-D-aspartate receptors in cocaine-seeking. Neuropharmacology. 2013; 75:9-18. PMC: 3865076. DOI: 10.1016/j.neuropharm.2013.07.001. View

2.
Sharf R, Ranaldi R . Blockade of muscarinic acetylcholine receptors in the ventral tegmental area disrupts food-related learning in rats. Psychopharmacology (Berl). 2005; 184(1):87-94. DOI: 10.1007/s00213-005-0235-9. View

3.
Threlfell S, Clements M, Khodai T, Pienaar I, Exley R, Wess J . Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J Neurosci. 2010; 30(9):3398-408. PMC: 2866006. DOI: 10.1523/JNEUROSCI.5620-09.2010. View

4.
Rada P, Colasante C, Skirzewski M, Hernandez L, Hoebel B . Behavioral depression in the swim test causes a biphasic, long-lasting change in accumbens acetylcholine release, with partial compensation by acetylcholinesterase and muscarinic-1 receptors. Neuroscience. 2006; 141(1):67-76. DOI: 10.1016/j.neuroscience.2006.03.043. View

5.
Zhang M, Balmadrid C, Kelley A . Nucleus accumbens opioid, GABaergic, and dopaminergic modulation of palatable food motivation: contrasting effects revealed by a progressive ratio study in the rat. Behav Neurosci. 2003; 117(2):202-11. DOI: 10.1037/0735-7044.117.2.202. View